A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 5, Pages 1092
Publisher
MDPI AG
Online
2017-05-23
DOI
10.3390/ijms18051092
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines
- (2016) Ata Abbas et al. Biochemistry and Cell Biology
- Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown
- (2016) Su-Hyeong Kim et al. BREAST CANCER RESEARCH AND TREATMENT
- The molecular hallmarks of epigenetic control
- (2016) C. David Allis et al. NATURE REVIEWS GENETICS
- Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer
- (2015) Rishabh Kala et al. BMC CANCER
- Breast cancer statistics, 2015: Convergence of incidence rates between black and white women
- (2015) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis
- (2015) Rajneesh Pathania et al. Nature Communications
- Requirement and Epigenetics Reprogramming of Nrf2 in Suppression of Tumor Promoter TPA-Induced Mouse Skin Cell Transformation by Sulforaphane
- (2014) Z.-Y. Su et al. Cancer Prevention Research
- Mechanistic Elucidation of the Antitumor Properties of Withaferin A in Breast Cancer
- (2014) A. Nagalingam et al. CANCER RESEARCH
- DNMT1-associated DNA methylation changes in cancer
- (2014) Pavel Bashtrykov et al. CELL CYCLE
- Cytostatic and Apoptotic Effects of DNMT and HDAC Inhibitors in Endometrial Cancer Cells
- (2014) Shaohua Xu et al. CURRENT PHARMACEUTICAL DESIGN
- Pharmacological Levels of Withaferin A (Withania somnifera) Trigger Clinically Relevant Anticancer Effects Specific to Triple Negative Breast Cancer Cells
- (2014) Katarzyna Szarc vel Szic et al. PLoS One
- Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation
- (2013) Huaping Chen et al. EXPERIMENTAL CELL RESEARCH
- Expression of DNA Methyltransferases in Breast Cancer Patients and to Analyze the Effect of Natural Compounds on DNA Methyltransferases and Associated Proteins
- (2013) Sameer Mirza et al. Journal of Breast Cancer
- Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
- (2013) Yuanyuan Li et al. Molecular Cancer
- Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane
- (2013) Huaping Chen et al. Journal of Oncology
- Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells
- (2012) Hee Jung Um et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression
- (2012) Eun-Ryeong Hahm et al. CANCER LETTERS
- Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed
- (2012) Berkley E Gryder et al. Future Medicinal Chemistry
- Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications
- (2012) Syed M. Meeran et al. PLoS One
- Withaferin A Synergizes the Therapeutic Effect of Doxorubicin through ROS-Mediated Autophagy in Ovarian Cancer
- (2012) Miranda Y. Fong et al. PLoS One
- Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A
- (2011) Xuan Zhang et al. GYNECOLOGIC ONCOLOGY
- Withaferin a suppresses estrogen receptor-α expression in human breast cancer cells
- (2011) Eun-Ryeong Hahm et al. MOLECULAR CARCINOGENESIS
- Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells
- (2011) John D. Clarke et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Withaferin A-Induced Apoptosis in Human Breast Cancer Cells Is Mediated by Reactive Oxygen Species
- (2011) Eun-Ryeong Hahm et al. PLoS One
- Anti-carcinogenic effects of sulforaphane in association with its apoptosis-inducing and anti-inflammatory properties in human cervical cancer cells
- (2010) Chhavi Sharma et al. Cancer Epidemiology
- Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
- (2010) Syed M. Meeran et al. PLoS One
- Correlation of mRNA and protein in complex biological samples
- (2009) Tobias Maier et al. FEBS LETTERS
- Dietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
- (2009) Emily Ho et al. JOURNAL OF NUTRITION
- Preclinicalversusclinical drug combination studies
- (2008) Ting-Chao Chou LEUKEMIA & LYMPHOMA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started